Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Neuroendocrine carcinoma of the breast--diagnostic and clinical implications.

Watrowski R, Jäger C, Mattern D, Horst C.

Anticancer Res. 2012 Nov;32(11):5079-82.

PMID:
23155283
2.

Neuroendocrine carcinomas of the breast.

Rovera F, Masciocchi P, Coglitore A, La Rosa S, Dionigi G, Marelli M, Boni L, Dionigi R.

Int J Surg. 2008;6 Suppl 1:S113-5. doi: 10.1016/j.ijsu.2008.12.007. Epub 2008 Dec 13.

3.

Solid neuroendocrine carcinoma of the breast.

Abbasi NZ, Zahur Z, Sheikh AS, Khan AA, Ali F, Memon KH, Moizuddin SS, Loya A, Barkat N.

J Coll Physicians Surg Pak. 2013 Nov;23(10):820-2. doi: 11.2013/JCPSP.820822.

PMID:
24169396
4.

Bilateral primary breast neuroendocrine carcinoma in a young woman: report of a case.

Zhang JY, Chen WJ.

Surg Today. 2011 Nov;41(11):1575-8. doi: 10.1007/s00595-010-4516-5. Epub 2011 Oct 4.

PMID:
21969166
5.

Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.

Angarita FA, Rodríguez JL, Meek E, Sánchez JO, Tawil M, Torregrosa L.

World J Surg Oncol. 2013 Jun 5;11:128. doi: 10.1186/1477-7819-11-128.

6.

Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma.

Yamamoto J, Ohshima K, Nabeshima K, Ikeda S, Iwasaki H, Kikuchi M.

Oncol Rep. 2004 Apr;11(4):825-31.

PMID:
15010880
7.

[Breast carcinoma with predominant neuroendocrine differentiation].

Frachon S, Pasquier D, Treilleux I, Seigneurin D, Ringeisen F, Rosier P, Bolla M, Boutonnat J.

Ann Pathol. 2004 Jun;24(3):278-83. Review. French.

PMID:
15480266
8.

Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.

Tang F, Wei B, Tian Z, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Zhang H, Sahin A, Chen J, Bu H, Abraham S, Wu Y.

Histopathology. 2011 Jul;59(1):106-15. doi: 10.1111/j.1365-2559.2011.03880.x. Epub 2011 Jun 13.

PMID:
21668471
9.

[Pure colloid carcinoma of the breast: anatomoclinical study of seven cases].

Chtourou I, Makni SK, Bahri I, Abbes K, Sellami A, Fakhfakh I, Gouiaa N, Ayadi L, Frikha M, Daoud J, Boudawara TS.

Cancer Radiother. 2009 Jan;13(1):37-41. doi: 10.1016/j.canrad.2008.06.004. Epub 2008 Aug 13. French.

PMID:
18703371
10.

Papillary-serous adenocarcinoma of the uterine cervix during tamoxifen therapy after bilateral breast cancer.

Watrowski R, Striepecke E, Jäger C, Bauknecht T, Horst C.

Anticancer Res. 2012 Nov;32(11):5075-8.

PMID:
23155282
11.

A case of primary small cell carcinoma of the breast.

Kitakata H, Yasumoto K, Sudo Y, Minato H, Takahashi Y.

Breast Cancer. 2007;14(4):414-9.

12.

[Primary neuroendocrine tumors of the breast: a retrospective study of 21 cases and literature review].

Feki J, Fourati N, Mnif H, Khabir A, Toumi N, Khanfir A, Boudawara T, Amouri H, Daoud J, Frikha M.

Cancer Radiother. 2015 Aug;19(5):308-12. doi: 10.1016/j.canrad.2015.04.003. Epub 2015 Jul 26. Review. French.

PMID:
26215367
13.

[Neuroendocrine carcinoma of the breast. Our experience and a proposal of a therapeutic algorithm for a rare tumor].

Scaramuzzi G, Murgo RM, Cuttitta A, Ciuffreda L.

G Chir. 2008 May;29(5):203-6. Italian.

PMID:
18507954
14.

Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.

López-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernadó L, Menendez JA.

Oncol Rep. 2008 Dec;20(6):1369-74.

PMID:
19020716
15.
16.

[Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].

Zhang HM, Zhang BN, Xuan LX, Zhao P.

Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):447-51. Chinese.

PMID:
19950556
17.

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR.

J Clin Oncol. 2008 May 10;26(14):2373-8. doi: 10.1200/JCO.2007.14.4287. Epub 2008 Apr 14. Erratum in: J Clin Oncol. 2008 Jun;26(18):3110.

PMID:
18413639
18.

Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.

Calais G, Berger C, Descamps P, Chapet S, Reynaud-Bougnoux A, Body G, Bougnoux P, Lansac J, Le Floch O.

Cancer. 1994 Aug 15;74(4):1283-8.

19.

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

BMC Cancer. 2007 Apr 12;7:63.

20.

A case of cytokeratin 20-positive large-cell neuroendocrine carcinoma of the breast.

Okoshi K, Saiga T, Hisamori S, Iwaisako K, Kobayashi H, Ogawa H.

Breast Cancer. 2012 Oct;19(4):360-4. doi: 10.1007/s12282-009-0160-6. Epub 2009 Aug 11.

PMID:
19669861

Supplemental Content

Support Center